Loading the map…
Manufacture of basic pharmaceutical products · Leeds
Rosemont Pharma Liquids
Rosemont Pharma Liquids Limited
Private limited company registered in Leeds, classed under “Manufacture of basic pharmaceutical products” and 1 other activity.
Headline figures
FY to Dec 2025 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
What the numbers say
1 finding from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2024 | 2025 |
|---|---|---|
| Profit after tax | — | |
| Turnover | ||
| Net assets | ||
| Cash | ||
| Employees |
Every figure for all 2 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2024 | 2025 |
|---|---|---|
| Current assets | ||
| Net current assets | ||
| Net assets |
3 balance-sheet lines, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Questions people ask
›What does Rosemont Pharma Liquids do?
Private limited company registered in Leeds, classed under “Manufacture of basic pharmaceutical products” and 1 other activity.
›How much turnover does Rosemont Pharma Liquids make?
Answered in the full report
›Is Rosemont Pharma Liquids profitable?
Rosemont Pharma Liquids's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Rosemont Pharma Liquids?
Answered in the full report
›Where is Rosemont Pharma Liquids based?
Its registered office is Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, LS11 9XE, in Leeds.
›When was Rosemont Pharma Liquids founded?
Rosemont Pharma Liquids Limited was incorporated on 3 June 2021.
›Is Rosemont Pharma Liquids still trading?
The register lists Rosemont Pharma Liquids Limited as active.